Rapid Heme Panel speeds treatment decisions for blood cancer patients

For patients with aggressive types of leukemia and other blood cancers, quickly identifying and starting the right treatment can make all the difference. In a major advance in the care of these patients, physicians at Dana-Farber/Brigham and Women's Cancer Center have begun using Rapid Heme Panel, a high-tech genetic test that provides, within a matter of days, an unprecedented amount of critical information to aid the choice of treatment.

http://ift.tt/11i2zCS